Moffitt Cancer Center Researchers Publish Book on Reproductive Health and Cancer in Adolescents and Young Adults

January 26, 2012

TAMPA, Fla. – Advances in treatment, screening and early diagnosis of cancer have turned a historically fatal diagnosis for children and adolescents into an 80 percent survival rate. The increase in adolescent and young adult (AYA) cancer survivors during the past 40 years demands a critical examination of the quality-of-life issues in survivorship, including fertility preservation and other reproductive health issues. This newly released book from Springer, “Reproductive Health and Cancer in Adolescents and Young Adults,” by Gwendolyn Quinn, Ph.D., and Susan Vadaparampil, Ph.D., analyzes the advances in reproductive health and fertility preservation options available to AYA oncology patients.

Based on the increasing availability of fertility preservation options and ethical guidelines of approaching AYA patients, this critical quality-of-life issue must be integrated into the overall AYA patient care. The authors provide an extensive review of the impact of cancer on reproductive health and options for maintaining reproductive health as a means of disseminating and raising awareness for these significant issues.

Brad Zebrack, associate professor of social work at the University of Michigan and cancer survivor, noted that “as a researcher and advocate whose work focuses on the quality of life for cancer survivors and their loved ones, I feel that this text is an invaluable educational resource that targets unique needs and issues faced by young adults fighting cancer during their reproductive years.”

For more information on the book, visit The book can be purchased on For more information, contact Nicole Hutchins at (813) 745-6941 or

About Moffitt Cancer Center

Follow Moffitt on Facebook:

Follow Moffitt on Twitter: @MoffittNews

Follow Moffitt on YouTube: MoffittNews

Located in Tampa, Moffitt Cancer Center is the only Florida-based National Cancer Institute Comprehensive Cancer Center, a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt has 14 affiliates in Florida, one in Georgia, one in Pennsylvania and two in Puerto Rico. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer.